Colestipol HCL 1 GM tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FCY6Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,569
Award facts
- Contract value 100% obligated
- $1,568.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,568.93 to AmerisourceBergen Drug Corp for the supply of Colestipol HCL 1 GM tablets (120-count package) on January 8, 2026, with completion scheduled for January 9, 2026. This is a firm fixed-price contract with no set-aside designation, awarded on a fully competitive basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order was issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of parent company Cencora, Inc. (formerly doing business as AmerisourceBergen), plays a critical role in supplying pharmaceutical products and medical commodities to federal military and healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement needs, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Through its prime indefinite delivery contract with DLA, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with this particular delivery order representing routine pharmaceutical supply fulfillment for the military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCY6Y?
SPE2DR26FCY6Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FCY6Y worth?
The government has obligated $1,569 on SPE2DR26FCY6Y.
Is contract SPE2DR26FCY6Y an order under another contract?
Yes. SPE2DR26FCY6Y is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY6Y competed?
The extent of competition for SPE2DR26FCY6Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award